SAN RAMON, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Al White, President and CEO, will represent the Company in a virtual session scheduled to begin at 2:15 PM ET. A live webcast of the presentation will be available to all interested parties on the Investor Relations section of CooperCompanies’ website at http://investor.coopercos.com. The webcast will be available for 30 days follow
HSIC vs. COO: Which Stock Is the Better Value Option?
SAN RAMON, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion. “We are excited to complete this transaction and welcome the Generate employees to